Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virtual Reality Analgesia for Spinal Injections
NCT03787147Phase 2Withdrawn
- Sponsor
- Albert Einstein College of Medicine
- Start
- Nov 2020
- Primary completion
- Dec 2020
01
Overview
Phase 2, randomised, open-label trial (3 arms), sponsored by Albert Einstein College of Medicine. Primary endpoint: Pain intensity as measured by the Visual Analog Scale. Planned start Nov 2020; status: withdrawn.
Beyond the preview
Go deeper on NCT03787147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787147.